Last10K.com

Inmode Ltd. (INMD) SEC Filing 20-F Annual Report for the fiscal year ending Friday, December 31, 2021

Inmode Ltd.

CIK: 1742692 Ticker: INMD

View differences made from one year to another to evaluate Inmode Ltd.'s financial trajectory

Compare SEC Filings Year-over-Year (YoY) and Quarter-over-Quarter (QoQ)
Sample 10-K Year-over-Year (YoY) Comparison

Compare this 20-F Annual Report to its predecessor by reading our highlights to see what text and tables were  removed  ,   added    and   changed   by Inmode Ltd..

Continue

Assess how Inmode Ltd.'s management team is paid from their Annual Proxy

Definitive Proxy Statement (Form DEF 14A)
Screenshot example of actual Proxy Statement

Inmode Ltd.'s Definitive Proxy Statement (Form DEF 14A) filed after their 2022 10-K Annual Report includes:

  • Voting Procedures
  • Board Members
  • Executive Team
  • Salaries, Bonuses, Perks
  • Peers / Competitors

Continue

Tools

Financial Statements, Disclosures and Schedules

Inside this 20-F Annual Report

Document And Entity Information
Consolidated Balance Sheets
Consolidated Balance Sheets (Parenthetical)
Consolidated Statements Of Cash Flows
Consolidated Statements Of Changes In Shareholders' Equity
Consolidated Statements Of Comprehensive Income
Consolidated Statements Of Income
Accounts Receivable
Accounts Receivable (Schedule Of Accounts Receivable) (Details)
Accounts Receivable (Tables)
Commitments And Contingent Liabilities
Commitments And Contingent Liabilities (Details)
Covid-19
Entity-Wide Disclosure
Entity-Wide Disclosure (Narrative) (Details)
Entity-Wide Disclosure (Schedule Of Changes In Contract Liabilities) (Details)
Entity-Wide Disclosure (Schedule Of Long-Lived Assets) (Details)
Entity-Wide Disclosure (Schedule Of Net Sales By Geographical Area) (Details)
Entity-Wide Disclosure (Schedule Of Net Sales By Techonology) (Details)
Entity-Wide Disclosure (Tables)
General
General (Details)
Inventories
Inventories (Schedule Of Inventories) (Details)
Inventories (Tables)
Leases
Leases (Narrative) (Details)
Leases (Schedule Of Lease Expense) (Details)
Leases (Schedule Of Maturities Of Lease Liabilities) (Details)
Leases (Schedule Of Supplemental Balance Sheet Information Related To Leases) (Details)
Leases (Schedule Of Supplemental Cash Flow Information Related To Leases) (Details)
Leases (Tables)
Marketable Securities And Fair Value Measurements
Marketable Securities And Fair Value Measurements (Narrative) (Details)
Marketable Securities And Fair Value Measurements (Schedule Of Debt Securities On Maturity) (Details)
Marketable Securities And Fair Value Measurements (Schedule Of Financial Assets Measured At Fair Value) (Details)
Marketable Securities And Fair Value Measurements (Schedule Of Marketable Securities) (Details)
Marketable Securities And Fair Value Measurements (Tables)
Other Current Liabilities
Other Current Liabilities (Schedule Of Other Liabilities) (Details)
Other Current Liabilities (Tables)
Other Current Receivables
Other Current Receivables (Schedule Of Other Current Receivables) (Details)
Other Current Receivables (Tables)
Other Investments
Other Investments (Details)
Property And Equipment, Net
Property And Equipment, Net (Schedule Of Property And Equipment) (Details)
Property And Equipment, Net (Tables)
Related Parties
Related Parties (Details)
Shareholders' Equity
Shareholders' Equity (Narrative) (Details)
Shareholders' Equity (Schedule Of Assumptions Used To Calculate Fair Value Of Options Granted) (Details)
Shareholders' Equity (Schedule Of Awards Authorized To Be Issued) (Details)
Shareholders' Equity (Schedule Of Grant Of Options) (Details)
Shareholders' Equity (Schedule Of Options Granted Resticted Share Unit) (Details)
Shareholders' Equity (Schedule Of Options Granted) (Details)
Shareholders' Equity (Schedule Of Outstanding And Exercisable Options) (Details)
Shareholders' Equity (Schedule Of Share Based Compensation Expense) (Details)
Shareholders' Equity (Tables)
Significant Accounting Policies
Significant Accounting Policies (Narrative) (Details)
Significant Accounting Policies (Policies)
Significant Accounting Policies (Schedule Of Accrued Warranty) (Details)
Significant Accounting Policies (Schedule Of Property And Equipment Estimated Useful Lives) (Details)
Significant Accounting Policies (Tables)
Subsequent Events
Subsequent Events (Details)
Taxes On Income
Taxes On Income (Narrative) (Details)
Taxes On Income (Schedule Of Deferred Tax Assets (Liabilities)) (Details)
Taxes On Income (Schedule Of Income Before Income Taxes) (Details)
Taxes On Income (Schedule Of Reconciliation Of Theoretical Provision For Income Tax) (Details)
Taxes On Income (Schedule Of Tax Expenses (Tax Benefit)) (Details)
Taxes On Income (Schedule Of Unrecognized Tax Benefits) (Details)
Taxes On Income (Tables)
Ticker: INMD
CIK: 1742692
Form Type: 20-F Annual Report
Accession Number: 0001178913-22-000512
Submitted to the SEC: Thu Feb 10 2022 7:05:16 AM EST
Accepted by the SEC: Thu Feb 10 2022
Period: Friday, December 31, 2021
Industry: Electromedical And Electrotherapeutic Apparatus

External Resources:
Stock Quote
Social Media

Bookmark the Permalink:
https://last10k.com/sec-filings/inmd/0001178913-22-000512.htm